Evaluation of renal functions in children with congenital heart disease before and after cardiac angiography

Turkish Journal of Pediatrics

Volumn 40, Issue 1, 1998, Pages 97-101

  Noyan, Aytül ^a   Küçükosmanoǧlu, Osman ^a   Yildizdaş, Dinçer ^a   Özbarlas, Nazan ^a   Anarat, Ali ^a   Anarat, Rüksan ^b  

^a CUKUROVA UNIVERSITY   (Turkey)

^b Düzen Laboratory   (Turkey)

Author keywords

Cardiac angiography; Radiocontrast nephrotoxicity

Indexed keywords

CONTRAST MEDIUM; IOTALAMIC ACID;

ADOLESCENT; ANGIOCARDIOGRAPHY; ARTICLE; CHEMICALLY INDUCED DISORDER; CHILD; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; CYANOSIS; FEMALE; HEART CATHETERIZATION; HUMAN; INFANT; KIDNEY DISEASE; KIDNEY FUNCTION TEST; MALE; METABOLISM; METHODOLOGY; NEWBORN; PRESCHOOL CHILD; PROSPECTIVE STUDY; RADIOGRAPHY; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CYANOSIS; FEMALE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; IOTHALAMIC ACID; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031608386     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. McClennan BL, Stolberg HO. Intravascular contrast media. Ionic versus nonionic: current status. Radiol Clin North Am 1991; 29: 437-454.
2. Davidson CJ, Hlatky M, Morris KG, et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 1989; 110: 119-124.
3. D'Elia JA, Gleason RE, Alday M, et al. Nephrotoxicity from angiographic contrast material. Am J Med 1982; 72: 719-725.
4. Tailercio CP, Vilestra R, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986; 104: 501-504.
5. Cramer BC, Parfrey PS, Hutchinson TA, et al. Renal function following infusion of radiologic contrast material. Arch Intern Med 1985; 145: 87-89.
6. Eisenberg RL, Bank WD, Hedglock MW. Renal failure after major angiography. Am J Med 1979; 68: 43-46.
7. Porter GA. Contrast-associated nephropathy. Am J Cardiol 1989; 64: 22E-26E.
8. Spear GS. The glomerulus in cyanolic congenital heart disease and primary pulmonary hypertension: a review. Nephron 1964; 1: 238-249.
9. Bushe J, Glasgow E, McCredia D, Powell H. Nephropathy of cyanotic congenital heart disease. Clin Nephrol 1977; 7: 38-42.
10. Meesen A, Litton MA. Morphology of the kidney in morbius coeruleus. Arch Pathol 1953; 56: 480-491.
11. Stonard MD. Proteins, enzymes and cells in urine as indicators of the site of renal damage. In: Bach PH, Lock EA (eds). Nephrotoxicity in the Experimental and Clinical Situation. Boston: Martinus Nijhoff Publishers; 1987: 563-592.
12. Flynn FV. Assesment of renal function: selected developments. Clin Biochem 1990; 23: 49-54.
13. Cavaliere G, Arrigo G, D'Amico G, et al. Tubular nephrotoxicity after intravenous urography with ionic high-osmolal and nonionic low-osmolar contrast media in patients with chronic renal insufficiency. Nephron 1987; 46: 128-133.
14. Kavukçu S, Tavli V, Fadillioǧlu M, et al. Urinary enzyme changes in children undergoing cineangiographic evaluation using ipromide. Int Urol Nephrol 1995; 27: 131-135.
15. Spinier SA, Goldfarb S. Nephrotoxicity of contrast media following cardiac angiography: pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media. Ann Pharmacother 1992; 26: 56-64.